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The growing prevalence of valvular heart
disease represents a major challenge in
terms of short-term and long-term manage-
ment and surveillance.1 2 Despite well-
deﬁned guidelines, appropriate detection
and follow-up strategies are still poorly
applied in valvular heart disease.3 4 In many
countries, valvular heart diseases are
managed by non-experts in the ﬁeld, which
may result in misdiagnosis and lead to
inappropriate delays in decisions about valve
interventions, and compromise patient
outcome. The establishment of multidiscip-
linary services delivered by experts in valvular
heart disease in a well-structured environ-
ment in order to provide specialised and
centralised evaluation, care and education to
patients with valvular heart disease has
become the basis of implementation of
‘Heart Valve Centre of Excellence’ across
Europe and outside Europe.5
Centres with a dedicated ‘Heart Valve Clinic’
have a designed pathway to diagnose and
monitor patients with valvular heart disease.
They regroup a multidisciplinary team of car-
diologists, nurses, radiologists, anaesthesiolo-
gists, and surgeons proﬁcient in diagnosing
and treating all cardiac valve syndromes and
disorders. This involves sophisticated cardiac
valve symptoms recognition, diagnostic techni-
ques such as three-dimensional echocardiog-
raphy, cardiac magnetic resonance, cardiac CT
and cardiac catheterisation.6 The ‘Heart Valve
Clinic’ also provides help in optimising and
monitoring medical treatment, assisting the
general cardiologists for clinical decision-
making, determining the correct timing and
type of intervention, referring the patient to
the most suitable surgeon, assessing results
after intervention, and informing patients to
motivate them to follow their prescribed medi-
cations and be alert for signs indicating a wor-
sening of their disease.1 2
The ‘Heart Valve Clinic’ model is generally
organised as a consultative cardiologist
nurse-based clinic that forms the basis for
the standard and advanced ‘Heart Valve
Clinic’ structure. The vast majority of patients
with valvular heart disease are suitable for
investigation in the ‘Heart Valve Clinic’.
However, prioritisation based on capacity, the
degree of valvular heart disease severity, and
the presence of an emergency condition
might be applied. In the UK, senior nurses
or sonographers are allowed to ensure sur-
veillance and monitoring of patients with
uncomplicated valve disease before and after
surgery.2 Applying this model of care, the
group of Chambers et al7 have shown that
the proportion of patients followed up
according to best practice guidelines rose
(from 41% to 92%), while the total number
of unwarranted echocardiograms performed
fell signiﬁcantly. Also, Rosenhek et al8
reported that the ‘wait’ for symptoms
approach is a safe strategy when carried out
in a ‘Heart Valve Clinic’. Surveillance in
these clinics seems to also improve adher-
ence to guidelines. However, despite this
growing body of observational evidence sup-
porting the notion that patient-centred care
is best delivered within these organised struc-
tures, their adoption across Europe remains
scanty, that is, 21% in the UK.5 Therefore,
clarifying the patient outcome and the eco-
nomic impact of such models of care repre-
sents a major goal for the ‘Heart Valve
Community’. Outcome studies are ongoing.
Several groups have merged their database,
that is, the HeArt ValvE Clinic group, to
enhance the clinical evidence of their
usefulness.9
In practice, the decision to refer the patient
for intervention is based on several factors:
valvular heart disease severity, symptoms,
degree of ventricular dysfunction, comorbid-
ities, interventional risk, skill of the surgical/
interventional team, patient preferences, and
so on. These factors are often difﬁcult to
assess, require speciﬁc training, and a high
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expertise in valvular heart disease imaging, need to inte-
grate newer risk stratiﬁcation indices, require to be
informed of recent changes in guidelines and cutting-edge
therapeutic options in valvular heart disease.2 3 All this
implies that professionals involved in the ‘Heart Valve
Centres of Excellence’ (advanced valve clinics model)
should have all the competencies to treat complex valvular
heart disease or high-risk patients, and deep knowledge in
the latest technologies and treatment methods (ie, valve
repair, percutaneous valve intervention). These centres,
thus, have all the facilities to treat and refer patients for
valvular surgery/intervention. Often, they have a high-
volume operation rate on valvular heart disease, which is
believed to be associated with better repair results and
potentially improved outcome.10 This partly explains why
there is no obligation to refer patients eligible for surgical
repair in centres of excellence.3 4
The present review paper of Chambers et al11 provides
us with the appropriate standards for best practice in
centres performing heart valve surgery. The strengths of
the paper are that this subject is of particular relevance
given this rapidly evolving ﬁeld. It speciﬁcally addresses
issues of multidisciplinary teams, including who the
actors are, and their level of expertise/specialisation,
levels of surgical experience and training, targets for sur-
gical outcomes, acceptable hospital procedure volumes,
and desirable national/international collaboration to
monitor new therapeutic devices. The authors called for
structured training programmes for the physicians and
staff involved in the patient periprocedural care that
should be performed under the umbrella of national
societies. The coordination and monitoring of specialist
training for all members of heart valve multidisciplinary
teams should be considered as a national matter. The
use of well-deﬁned care pathways likely supports health-
care teams in implementing evidence-based key inter-
ventions and reduce clinical variations in everyday
practice. As for other cardiovascular interventions,
national cardiovascular professional societies should set
up databases recording all valve implantations. Results of
surgery should be readily available to patients, referrers
and government agencies. This means that, ideally, uni-
versal entry onto national databases should be required.
These data should include rates of residual regurgitation
for mitral valve repairs and reoperation rates matched to
the preoperative pathology and risk. Decisions about
intervention at the ‘Heart Valve Centres of Excellence’
should thus be dependent on the centres’ publicly avail-
able mortality rates and operative outcomes4 (ﬁgure 1).
Therefore, ‘Heart Valve Centres of Excellence’ may not
necessarily have expertise in all valve problems. All this
is consistent with the deﬁnition of best practices and the
need for careful control of standards. In fact, the
importance of quality control in healthcare is steadily
increasing.12 Over the upcoming years, measurements of
quality of care will likely become more and more a
public product, used by patients, providers and ofﬁcial
national institutions. This information should serve as
an important guide for improvement, as well as a deci-
sion support tool for healthcare providers in charge of
patients with valvular heart disease. The data capture
should thus become integral to routine patient care.
Common reporting systems could be used by national
societies across Europe, which could serve to strengthen
the missions of the ‘Heart Valve Centres of Excellence’
performing heart valve surgery. However, how to cross-
fertilise the existing variety of national systems remains
to be deﬁned. The European Society of Cardiology
Working Group on Valvular Heart Disease could
become a major player in disseminating the concept of
centres of excellence.
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